Cdc20 Antibodies

Santa Cruz Biotechnology features a diverse variety of Cdc20 monoclonal antibodies for research in cell cycle regulation and cancer biology. Cdc20 monoclonal antibodies are suitable for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Cdc20, a crucial activator of the anaphase-promoting complex/cyclosome (APC/C), plays a significant role in the regulation of the cell cycle, particularly in the transition from metaphase to anaphase. Dysregulation of Cdc20 is often associated with various cancers, making it a vital target for therapeutic intervention and biomarker discovery. Understanding Cdc20 function is essential for elucidating the mechanisms of cell division and the development of cancer. Researchers can explore the complex interactions between Cdc20 and other cell cycle regulators using specific detection methods. Advanced visualization techniques enable detailed examination of Cdc20 localization and expression patterns throughout different cell cycle phases. Multiple conjugation options, including horseradish peroxidase (HRP), phycoerythrin (PE), and fluorescein isothiocyanate (FITC), provide flexibility in experimental design. Santa Cruz Biotechnology monoclonal antibodies support cutting-edge research that advances our understanding of cell cycle regulation and its impact on human health.